Company intelligence

KALA

Kala Pharmaceuticals, Inc. · NASDAQ · Healthcare

Price$0.56-16.89% · −$0.11

Market cap10.81MEquity value

P / E-0.2Trailing ratio

Volume8.15MLatest session

Market data

KALA price chart

TradingView

Related signals

1 min delayed

Browse public KALA signals with their source context and measured market impact. Open any signal for its permanent analysis page.

KALAMar 30, 2026-0.68% since signal

Kala Bio Launches AI Research Agent BIRA, Signifying Market Opportunity

Kala Bio has officially launched its Bionic Intelligence Research Agent (BIRA), marking a significant milestone in its strategy to become a leader in AI-driven biotech solutions. This development positions the company to tap into a crucial market segment facing substantial challenges in research efficiency, compliance, and competitive intelligence.

View signal analysis

KALASep 29, 2025-27.80% since signal

Why Is Eye Disease Focused Kala Bio Stock Plunging On Monday?

KALA halted development of KPI-012 after trial failure. CHASE Phase 2b trial failed to meet primary endpoint. Company plans workforce reductions and cost-saving measures. KALA's stock fell 91.44% to $1.63 after the announcement. It has cash reserves to fund operations until Q1 2026.

View signal analysis

Research